McKesson Specialty Health to acquire intraFUSION
The transaction is expected to close early in the second half of 2017. Following the close of the transaction, intraFUSION will become part of McKesson’s specialty health business, offering a single-source manager to providers who are treating patients in their offices with infused medications for complex disease management.
“McKesson Specialty Health is dedicated to the success of specialty providers,” said Nick Loporcaro, president, McKesson Specialty Health. “McKesson Specialty Health’s acquisition of intraFUSION will further support community physicians’ delivery of high-quality care.”
“McKesson Specialty Health and intraFUSION share a deep commitment to community-based specialty care,” said Carl Lampart, CEO of intraFUSION. “Joining forces with McKesson Specialty Health will amplify the positive impact intraFUSION can deliver for its customers in an increasingly complex healthcare environment.”
About McKesson Specialty Health
McKesson Specialty Health, a division of McKesson Corporation, works together with stakeholders across the healthcare delivery system to preserve and strengthen specialty care, passionately driven by the benefits it provides patients and the system as a whole. Through innovative provider, practice management, manufacturer and payer solutions, McKesson Specialty Health focuses on improving the financial, operational and business health of our customers and partners so they may provide the best care to patients. At McKesson Specialty Health, we believe that we are all in this together. For more information, visit www.mckessonspecialtyhealth.com.
Комментарии